Cargando…

Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF(10)-DEIA-LiPA(25) (Version 1) Platform Compared to Type-Specific Real-Time Quantitative PCR Assays and Impact on Vaccine Effectiveness Estimates

Human papillomavirus (HPV) epidemiological and vaccine studies require highly sensitive HPV detection systems. The widely used broad-spectrum SPF(10)-DEIA-LiPA(25) (SPF(10) method) has reduced sensitivity toward HPV-45 and -59. Therefore, anogenital samples from the PASSYON study were retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Eer, Kahren, Leussink, Suzan, Severs, Tim T., van Marm-Wattimena, Naomi, Woestenberg, Petra J., Bogaards, Johannes A., King, Audrey J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Virology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587105/ https://www.ncbi.nlm.nih.gov/pubmed/32907991 http://dx.doi.org/10.1128/JCM.01626-20

Ejemplares similares

Oral HPV prevalence assessment by Linear Array vs. SPF(10) PCR-DEIA-LiPA(25) system in the HPV Infection in Men (HIM) study
por: Bettampadi, Deepti, et al.
Publicado: (2020)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay
por: Nilyanimit, Pornjarim, et al.
Publicado: (2017)

Assessment of herd effects among women and heterosexual men after girls‐only HPV16/18 vaccination in the Netherlands: A repeated cross‐sectional study
por: Woestenberg, Petra J, et al.
Publicado: (2018)

HPV vaccination and sexual behaviour in healthcare seeking young women in Luxembourg
por: Soudeyns, Camille, et al.
Publicado: (2020)

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel
por: Polman, N. J., et al.
Publicado: (2017)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework
por: Dhillon, Sharonjit K., et al.
Publicado: (2021)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors
por: Woestenberg, Petra J, et al.
Publicado: (2018)

Frequency of Human Papilloma Virus (HPV) subtypes 31,33,35,39 and 45 among Yemeni women with cervical cancer
por: Ahmed, Hussain Gadelkarim, et al.
Publicado: (2015)

Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females
por: van der Weele, Pascal, et al.
Publicado: (2019)

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany
por: Iftner, Thomas, et al.
Publicado: (2019)

Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
por: Xu, Lan, et al.
Publicado: (2018)

HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer
por: Amaro-Filho, Sérgio Menezes, et al.
Publicado: (2018)

Drosophila SPF45: A Bifunctional Protein with Roles in Both Splicing and DNA Repair
por: Chaouki, Ahmad Sami, et al.
Publicado: (2006)

Attitudes toward HPV Vaccination among Women Aged 27 to 45
por: Weiss, Thomas W., et al.
Publicado: (2011)

Development of Antibodies against HPV-6 and HPV-11 for the Study of Laryngeal Papilloma
por: Ikegami, Taro, et al.
Publicado: (2021)

Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix(®) or Gardasil(®) Vaccine
por: Godi, Anna, et al.
Publicado: (2015)

An analysis of the knowledge of adults aged between 18 and 45 on HPV along with their attitudes and beliefs about HPV vaccine: the Cyprus case
por: Yarıcı, Filiz, et al.
Publicado: (2023)

Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion
por: Liu, Yuying, et al.
Publicado: (2013)

Integrative analyses reveal novel strategies in HPV11,-16 and -45 early infection
por: Kaczkowski, Bogumil, et al.
Publicado: (2012)

Health Literacy Correlates to HPV Vaccination Among US Adults Ages 27–45
por: Galvin, Annalynn M., et al.
Publicado: (2022)

DEIA is essential to advance the goals of translational science: Perspectives from NCATS
por: Hussain, Shadab F., et al.
Publicado: (2022)

Knowledge of Cervical Cancer, Human Papilloma Virus (HPV) and HPV Vaccination Among Women in Northeast China
por: Ning, Yu-e, et al.
Publicado: (2019)

Knowledge of human papilloma virus (HPV), HPV-vaccine and pap smear among adult Saudi women
por: Al Ghamdi, Nada H.
Publicado: (2022)

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2010)

Knowledge of Cervical Cancer and HPV, and Willingness to Receive HPV Vaccination Among 20–45-Year-Old Women — Six Provinces, China, 2018
por: Gao, Di, et al.
Publicado: (2023)

Health Care System View of Human Papilloma Virus (HPV) Vaccine Acceptability by Emirati Men
por: Al Shdefat, Suzan, et al.
Publicado: (2022)

Human Papilloma Virus (HPV) and Fertilization: A Mini Review
por: Zacharis, Konstantinos, et al.
Publicado: (2018)

HPV‐positive oral papillomas in an adolescent—A diagnostic dilemma
por: Benyo, Sarah, et al.
Publicado: (2021)

HPV vaccination in women aged 27 to 45 years: what do general practitioners think?
por: Mazza, Danielle, et al.
Publicado: (2014)

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2017)

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years
por: Maldonado, Ivette, et al.
Publicado: (2022)

Coincidence of HPV11-Positive Urethral Condyloma Acuminatum and HPV-Negative Multiple Bladder Papillomas in a Female
por: Nakazaki, Natsuko, et al.
Publicado: (2012)

Multiple Human Papilloma Virus (HPV) Infections Are Associated with HSIL and Persistent HPV Infection Status in Korean Patients
por: Kim, Moonsik, et al.
Publicado: (2021)

Alternative splicing regulation of cell-cycle genes by SPF45/SR140/CHERP complex controls cell proliferation
por: Martín, Elena, et al.
Publicado: (2021)

Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches
por: Donken, R., et al.
Publicado: (2020)

Pricing of HPV vaccines in European tender-based settings
por: Qendri, Venetia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qrs2vam2u3j0qsuh2nj88ujmgv